Mirae Asset Global ETFs Holdings
XBIT icon

Mirae Asset Global ETFs Holdings’s XBiotech XBIT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,873
Closed -$38.5K – 3262
2025
Q1 		$38.5K Buy
11,873
+483
+4% +$1.67K ﹤0.01% 2892
2024
Q4 		$45K Buy
11,390
+1,236
+12% +$8.43K ﹤0.01% 2922
2024
Q3 		$78.5K Buy
+10,154
New +$66.7K ﹤0.01% 2801

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's XBIT Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of XBiotech (XBIT) in Q2 2025, closing a stake of 11,873 shares — an estimated $38.5K sold.

Mirae Asset Global ETFs Holdings first reported a position in XBIT in Q3 2024 and held it in 3 quarters. The position peaked at $78.5K in Q3 2024. 53 funds tracked by Wall St. Rank hold XBIT as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining XBiotech position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 11,873 XBiotech shares in Q2 2025, an estimated $38.5K.
  • Mirae Asset Global ETFs Holdings first reported a position in XBiotech in Q3 2024 and held it in 3 quarters.
  • Mirae Asset Global ETFs Holdings's XBiotech position peaked at $78.5K in Q3 2024.
  • 53 funds tracked by Wall St. Rank held XBiotech as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.